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Abstract — Aims: To assess the efficacy of rosiglitazone in blocking ethanol-induced hangover in rats. Methods: Rats injected with
ethanol (4 g/kg body weight) were subjected to social interaction tests. Levels of aldehyde dehydrogenase 2 (ALD2), involved in an
anti-hangover mechanism, were measured by semi-quantitative RT–PCR and western blot analysis. Results: Rosiglitazone caused an
upregulation of mitochondrial ALD2, thus significantly detoxifying acetaldehyde. Conclusions: Rosiglitazone alleviated the symptoms
of ethanol-induced hangover by inducing ALD2 expression; this result was reconfirmed by eliminating the effect of rosiglitazone by
injecting cyanamide, an ALD2 inhibitor.
INTRODUCTION
Although ethanol has been used to reduce stress, excessive
ethanol consumption can have serious negative social conse-
quences. Alcoholism is not a simple problem of heavy
drinking. It substantially damages individuals’ mental and
physical health. Symptoms of ethanol abuse include vomiting,
dizziness, thirst, headaches and muscle pain (Swift and
Davidson, 1998). Chronic ethanol consumption leads to
liver damage, pancreatitis, myocardial infarction and neuro-
pathy and exacerbates the symptoms of tuberculosis and other
diseases (Lieber and Leo, 1986, 1992).
Most ethanol consumed is metabolized by aldehyde/alcohol
dehydrogenase (ALD), a microsomal ethanol-oxidizing
system, and catalase, and by peroxidase in the liver; the
remainder is emitted via the kidney and lung. Ethanol admin-
istration causes more damage to the liver than to any other
organ (Lieber and DeCarli, 1968; Goodman and Gilman,
1975; Lieber, 1985; Lieber and Leo, 1986). Therefore, the
efficient detoxification of ethanol is crucial for the preserva-
tion of proper liver function.
Acetaldehyde is known to be a primary metabolite of etha-
nol and is the main cause of hangovers (Kim, 1994). Lieber
reported acetaldehyde to be more toxic to the body than etha-
nol itself (Lieber, 1973). It has been reported that acetaldehyde
causes steatohepatitis, hepatic cirrhosis, downregulation of
ALD2 expression and impaired vitamin activity via mitochon-
drial dysfunction (Helander, 1988). Therefore, problems of
ethanol toxicity can potentially be solved by effectively
decreasing the plasma acetaldehyde concentration.
Rosiglitazone, a class of insulin-sensitizing thiazolidine-
dione (TZD) drugs, is a peroxisome proliferator-activated
receptor (PPAR)-g agonist. It has been widely used for treat-
ing hyperglycaemia and improving insulin resistance (Patel
et al., 1999). The metabolic effects of TZDs are mediated by
receptor-dependent activation of the PPAR-g–retinoid
X receptor (RXR) complex and subsequent transcriptional
activation of target genes (Yki-Jarvinen, 2004). Interestingly,
TZDs may also be potent inhibitors of inflammation, in part
through receptor-independent mechanisms (Chawla et al.,
2001; Takata et al., 2002; Ruan et al., 2003; Mohanty et al.,
2004). It is also thought that the anti-inflammatory effects of
TZDs may reduce the risk of cardiovascular disease (van
Wijk and Rabelink, 2004). There has been one report that
the ALD2 promoter contains PPAR response elements
(PPREs) (Pinaire et al., 1999). Thus, the expression of
ALD2 could potentially be regulated by rosiglitazone.
The purpose of this study was to assess the effects of rosigli-
tazone on ALD2 expression and associated symptoms of
ethanol-induced hangover.
MATERIALS AND METHODS
Animals and study design
Four-week-old male Sprague–Dawley (SD) rats were pur-
chased from Samptako (O San, Korea) and were housed
(two per cage) under 12 h light/dark cycles with ad libitum
access to food and water for 24 weeks. Half of the animals
(total n = 48) were given 5 mg/kg body weight of rosiglitazone
orally for 2 weeks along with standard lab chow ad libitum.
Because rosiglitazone was originally a metabolic disease
drug, it needs time to induce ALD2 expression. This was
confirmed in in vitro experiments using HepG2 cells (data
not shown). After pre-treatment with rosiglitazone, the rats
were given one 4 g/kg body weight dose of ethanol orally
(AR, n = 14) or saline (A, n = 10) (Gauvin et al., 1992).
Then 10 mg/kg body weight of cyanamide was administered
to rosiglitazone plus ethanol-treated rats (ARI, n = 7) by intra-
peritoneal injection as an ALD2 inhibitor. Animals not treated
with rosiglitazone (C, n = 24) were given standard lab chow ad
libitum. The animals were given a 10 min social interaction
test. Independent rat tissue samples under the same conditions
were harvested according to time-dependent plasma alcohol
concentration (Fig. 1).
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Determination of plasma ethanol concentration
The plasma ethanol concentration was determined using a
rapid analyzer (GL5, Analox Instruments, Lunenburg, MA).
The plasma ethanol concentrations in three groups for 8 h
are shown in Fig. 1. All experiments using rats were per-
formed in compliance with the European Community Guide
for the care and use of Laboratory Animals.
A social interaction test
Overall social activity was scored as the sum of social investi-
gation, contact and play behaviour frequencies. Social investi-
gation was defined as sniffing of any part of the partner’s
body. Frequency of contact behaviour was scored as the sum
of crawling over and under the partner and social grooming.
Play fighting was scored by the frequencies of the following
behavioural acts and postures demonstrated by test subjects:
pouncing or playful nape attack (the experimental subject
lunges at the partner with its forepaws extended outward), fol-
lowing and chasing (the experimental animal rapidly pursues
the partner) (Meaney and Stewart, 1981; Thor and Holloway,
1984; Vandershuren et al., 1997). The total number of cross-
overs (movements between compartments) demonstrated by
each experimental subject was used as an index of general
locomotor activity (Varlinskaya and Spear, 2002). The fre-
quency of social investigation, contact behaviour and play
fighting and the total number of crossovers were examined
using separate between-group ANOVAs.
Immunoblot analysis
Immunoblot analysis was performed using crude extracts
from liver tissue. Samples were resolved by 10% SDS–
polyacrylamide gel electrophoresis, transferred to nitro-
cellulose membrane and blotted with appropriate primary
antibodies. The membrane was incubated with peroxidase-
conjugated secondary antibodies (1:5000; Santa Cruz Bio-
technology, Santa Cruz, CA) and the bound antibody
was visualized using a chemiluminescence reader (Intron,
Sungnam, Korea) and X-ray film (Fuji Film, Uetake, Japan).
The primary antibody, mouse anti-ALD2, was purchased as
synthesized peptides from Peptron (1:1000; Daejeon, Korea).
Isolation of mitochondrial fraction
Tissue lysates were washed in buffer A (100 mM sucrose,
1 mM EGTA and 20 mM MOPS, pH 7.4) and resuspended
in buffer B [buffer A plus 5% Percoll, 0.01% digitonin and a
cocktail of protease inhibitors: 10 mM aprotinin, 10 mM pep-
statin A, 10 mM leupeptin, 25 mM calpain inhibitor I and
1 mM phenylmethylsulfonyl fluoride (PMSF)]. After 15 min
of incubation on ice, unbroken cells and nuclei were pelleted
by centrifugation at 2500 g for 10 min. The supernatant was
centrifuged at 15 000 g for 15 min to pellet mitochondria,
which were resuspended in buffer C [300 mM sucrose, 1 mM
EGTA, 20 mM MOPS (pH 7.4) and the aforementioned cock-
tail of protease inhibitors]. The supernatant was centrifuged
further at 100 000 g for 1 h. The resulting supernatant and
the pellet were designated as the cytosolic and microsomal
fractions, respectively. The nuclear pellet was resuspended
in 10 mM Tris–HCl (pH 7.5), 2.5 mM KCl and 2.5 mM
MgCl2 and isolated after centrifugation at 90 000 g for
30 min through use of 2.1 M sucrose in 50 mM Tris–HCl
(pH 7.5) and 5 mM MgCl2.
ALD2 activity assay
The mitochondrial fraction was used to assay the catalytic
activity of ALD2. ALD2 catalytic activity was assayed by
measuring the increase of absorbance at 340 nm due to the
reduction of NAD+ to NADH following the oxidation of acet-
aldehyde to acetic acid. The assay method has been described
previously (Bostian and Betts, 1978), but was adapted to a 96-
well microplate reader using a final volume of 0.2 ml.
RESULTS
Ethanol-induced hangover causes suppressed social investiga-
tion in rats, as illustrated in Fig. 2A for our four groups of rats
18 h after ethanol challenge. In contrast to the hangover-
associated suppression observed in the ethanol-treated group,
rosiglitazone-treated rats showed recovery from hangover-
associated social investigation suppression, but not comple-
tely. Rosiglitazone plus cyanamide-treated rats did not show
a rosiglitazone effect. General locomotor activity (as indexed
by the total number of crossovers between compartments)
was significantly lower in ethanol-treated rats than in control
and in ethanol plus rosiglitazone-treated rats. Decreased loco-
motor activity during acute ethanol withdrawal (hangover) has
also been reported in adult animals tested on the elevated plus
maze (Lal et al., 1991; File et al., 1993). Social investigation
and contact behaviour tests showed the same patterns as the
crossovers tests. But play fighting was not detected in any
group (Fig. 2A). As expected, overall social activities were
shown to vary among the groups (Fig. 2B).
Because we found behavioural changes in the social interac-
tion test following rosiglitazone treatment, we decided to
Fig. 1. Plasma ethanol concentration in experimental rats. Data are
means ± SD (n = 4). *P < 0.05, ethanol-treated and ethanol plus
rosiglitazone-treated group compared with the control group. The difference
between the ethanol-treated and ethanol plus rosiglitazone-treated groups
was not significant (N.S.). C, control (closed circle); A, ethanol 4 g/kg body
weight treatment (open circle); AR, ethanol plus rosiglitazone 5 mg/kg body
weight/day treatment (closed triangle).
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confirm the relationship of rosiglitazone treatment to ALD2
expression. To analyze aldehyde metabolism, expression of
ALD2, which is known to catalyze aldehyde, was assessed
by western blot analysis in the four groups. As shown in
Fig. 3A, ALD2 expression was higher in rosiglitazone-
treated rat livers than in those of control and ethanol-treated
rats. But cyanamide influenced only ALD2 activity, not its
expression (Fig. 3B).
Fig. 2. Social investigation, contact behaviour, play fighting and locomotor activity (overall number of crossovers) during the test session, 18 h after an acute
ethanol challenge (A). Overall social activity was scored as the sum of social investigation, contact, play fighting and crossover frequencies (B). Data for familiar
and unfamiliar situations were similar (data not shown). Cyanamide-only treatment was also tested, but that group was not significantly different from the control
group. Data are means ± SD. *P < 0.05, compared with the control group; +P < 0.05, compared with the ethanol treatment group; #P < 0.05, compared with the
ethanol plus rosiglitazone treatment group. C, control; A, ethanol 4 g/kg body weight treatment; AR, ethanol plus rosiglitazone 5 mg/kg body weight/day treat-
ment; ARI, ethanol plus rosiglitazone plus cyanamide 10 mg/kg body weight treatment.
Fig. 3. ALD2 expression and activity in experimental rats. ALD2 expression was determined by western blot analysis. The expression of ALD2 was estimated by
densitometric analysis of each protein band (A). ALD2 activity was measured (B). Cyanamide-only treatment was also tested, but that group was not significantly
different from the control group. Data are means ± SD (n = 4). *P < 0.05, compared with the control group; +P < 0.05, compared with the ethanol treatment
group; #P < 0.05, compared with the ethanol plus rosiglitazone treatment group. C, control; A, ethanol 4 g/kg body weight treatment; AR, ethanol plus rosiglita-
zone 5 mg/kg body weight/day treatment; ARI, ethanol plus rosiglitazone plus cyanamide 10 mg/kg body weight treatment.
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DISCUSSION
Hangover-related anxiety can be indexed in laboratory ani-
mals by assessing the suppression of social interactions nor-
mally seen when two animals are placed together (social
inhibition). Social interaction tests have been effectively
applied to the investigation of anxiety-related behaviour in
rats (File and Seth, 2003) including behaviours related to etha-
nol withdrawal (File et al., 1989, 1991, 1992). The social
interaction test is a model of generalized anxiety (File, 1995)
and has several advantages over other animal models of anxi-
ety. It does not involve ecologically unusual conditions such
as food and water deprivation or the use of electric shock.
The social interaction test does not require extensive pre-
training procedures and, hence, can be easily applied to the
assessment of hangover-related anxiety in rats. In the conven-
tional social interaction test, a pair of rats is placed in an
experimental cage and the time that they spend in active social
interaction is recorded. A summed measure of a variety of dif-
ferent elementary behavioural acts, including sniffing, groom-
ing, chasing and wrestling, crawling under or over, nape
attacks and biting, has traditionally been used for assessment
of anxiogenic drug effects in this test situation. However,
rats engage in distinct forms of interactive social behaviours
that include social investigation, contact behaviour and play
fighting. Each of these forms of social activity is influenced
differently by drug treatment (Beatty et al., 1982; Soffie and
Bronchart, 1988; Vandershuren et al., 1997), has a distinct
ethological pattern (Meaney and Stewart, 1981; Panksepp
et al., 1984; Thor and Holloway, 1984; Vandershuren et al.,
1997) and hence may be mediated by different neural systems.
This study assessed the effects of acute ethanol hangover on
different forms of social behaviour (social investigation, con-
tact behaviour and play fighting) in control, ethanol-treated,
ethanol plus rosiglitazone-treated and rosiglitazone-only-
treated rats. The results of this study indicate that rosiglitazone
reversed ethanol’s depression of social activities and that it is
able to eliminate acetaldehyde by regulating the expression of
ALD2.
As expected, we confirmed more induced ALD2 expression
in ethanol plus rosiglitazone-treated rats than in rats treated
with ethanol only. Thus, we supposed that rosiglitazone
enabled recovery from hangover in rats by effectively decreas-
ing the plasma acetaldehyde concentration. The social activ-
ities of rosiglitazone-only-treated rats were similar to those
of the controls (data not shown)
Unfortunately, we could not directly measure plasma acet-
aldehyde concentrations because of acetaldehyde’s highly
evaporative nature and the potential for measurement inaccu-
racy in our laboratory setting. But we used the second best
option: we solved the problem by treating rats with cyana-
mide, an ALD2 inhibitor. Cyanamide eliminated the effects
of rosiglitazone in the social interaction test (Fig. 2) as well
as ALD2 activity (Fig. 3B) without changing the ALD2
expression level (Fig. 3).
Interestingly, the present study shows that rosiglitazone
may be able to decrease plasma acetaldehyde concentration
in a time-dependent manner without changing plasma ethanol
concentrations (Fig. 1). This result shows that rosiglitazone
can selectively eliminate the very toxic effects of acetaldehyde
by inducing ALD2 expression.
In summary, our results show that rosiglitazone combats
ethanol-induced hangover in rats. These results may open up
a new clinical avenue for treating acute and severe ethanol-
induced hangover. Further studies of the anti-hangover
mechanism and ALD2 mechanism of rosiglitazone are neces-
sary, and the cost of rosiglitazone needs to be reduced if it is to
be used as a simple anti-hangover drug.
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